Viatris Plots January Investor Day To Flesh Out Longer-Term Roadmap

As The Street Awaits Details Of Post 2023 Investment And Strategy

sales surge
Viatris has once again raised its 2021 year financial guidace • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Business

More from Generics Bulletin